Faro

Faro makes software that takes clinical researchers to the next level. Our mission is to improve the lives of patients by empowering teams to conduct more effective clinical research faster. While other areas of life sciences have benefited from software development, clinical trials are still mostly designed and communicated in Word documents.

Health and bio

Faro raised $37.3M in a Series B+ round announced August 26, 2026, according to finsmes.com. Investors in that round: S32.

Raise history

1. September 29, 2026
   First seen by Recent Funding
   via startups.gallery
2. August 26, 2026
   Series B+ · $37.3M
   SS32 (lead)
   Source: finsmes.com (startups.gallery listing)

Investors

• SS32

Related other companies

• QQuartermaster$140M · Sep 28, 2026
• SSnorkel AI$350M · Sep 23, 2026
• EEnveda$311M · Sep 23, 2026
• HHeidi Health$100M · Sep 22, 2026
• FFirecrawl$75M · Sep 22, 2026
• CCorridor$25M · Sep 21, 2026
• JJack & Jill$40M · Sep 19, 2026
• MMithr Inc.$20M · Sep 19, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/faro.